Original Basis Of Design

Novo Nordisk intends to increase the Flex Pen assembly and packaging capacity at Novo Nordisk Pharmaceutical Industries, Inc. (NNPII) production facility in Clayton, NC. To that end, Novo Nordisk plans to evaluate options for expanding the FlexPen® assembly line warehouse and packaging areas for the FlexPen® product at the Clayton, NC facility.

This Basis of Design (BOD) document focuses primarily on the currently preferred option for this expansion (Option 1).

For Option 1, the total estimated build-out will contain approximately 92,000 sq-ft of new space.

This proposed expansion will include the following features:

• expanded manufacturing to accommodate one assembly line and one packaging line with the capability to add a future assembly or packaging line;
• a new warehouse with dedicated +5°C cold storage warehouse for in-process and finished FlexPens®, and a dedicated ambient FlexPen® component and label warehouse;
• a second floor office area, including space initially for 46 new work stations and 6 quiet rooms;
• a loading dock on the north side of the expansion designed to accommodate two truck positions.